Prospective, randomized, double-blind placebo controlled study on influenza vaccination in prevention from coronary events in patients with coronary artery disease confirmed by angiography

Trial Profile

Prospective, randomized, double-blind placebo controlled study on influenza vaccination in prevention from coronary events in patients with coronary artery disease confirmed by angiography

Completed
Phase of Trial: Phase II/III

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Acute coronary syndromes; Coronary artery disease; Coronary disorders; Death; Myocardial infarction
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms FLUCAD
  • Most Recent Events

    • 20 Apr 2010 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 02 Sep 2009 The effect of influenza vaccination on coronary ischaemic events overall and in subgroups of participants has been published as an abstract at the Annual Congress of the European Society of Cardiology (ESC 2009).
    • 21 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top